摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(2RS,4R)-2-(1,3-diphenyl-1H-pyrazol-4-yl)thiazolidine-4-carboxamide | 1262005-12-8

中文名称
——
中文别名
——
英文名称
(2RS,4R)-2-(1,3-diphenyl-1H-pyrazol-4-yl)thiazolidine-4-carboxamide
英文别名
(4R)-2-(1,3-diphenylpyrazol-4-yl)-1,3-thiazolidine-4-carboxamide
(2RS,4R)-2-(1,3-diphenyl-1H-pyrazol-4-yl)thiazolidine-4-carboxamide化学式
CAS
1262005-12-8
化学式
C19H18N4OS
mdl
——
分子量
350.444
InChiKey
MQZMOJGPULPIFR-UCFFOFKASA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.5
  • 重原子数:
    25
  • 可旋转键数:
    4
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.16
  • 拓扑面积:
    98.2
  • 氢给体数:
    2
  • 氢受体数:
    4

反应信息

  • 作为产物:
    描述:
    tert-butyl (4R)-4-carbamoyl-2-(1,3-diphenylpyrazol-4-yl)-1,3-thiazolidine-3-carboxylate盐酸苯甲醚 作用下, 以 1,4-二氧六环 为溶剂, 以75%的产率得到(2RS,4R)-2-(1,3-diphenyl-1H-pyrazol-4-yl)thiazolidine-4-carboxamide
    参考文献:
    名称:
    Synthesis and biological evaluation of some thiazolylpyrazole derivatives as dual anti-inflammatory antimicrobial agents
    摘要:
    The synthesis of a novel series of 4-thiazolylpyrazolyl derivatives is described in the present report. All the newly synthesized compounds were examined for their anti-inflammatory activity using cotton pellet-induced granuloma and carrageenan-induced rat paw edema bioassays. Their inhibitory activities of cyclooxygenase-1 and cyclooxygenase-2 (COX-1 and COX-2), ulcerogenic effect and acute toxicity were also determined. Furthermore, all compounds were evaluated for their in vitro antimicrobial activity against Escherichia coli. Staphylococcus aureus and Candida albicans. A docking pose for compounds 8b, 10a and 10b separately in the active site of the human COX-2 enzyme and DNA-gyrase B was also obtained. The results revealed that compounds 8b, 10a and 10b exhibited good anti-inflammatory activity with no or minimal ulcerogenic effect and good safety margin. Compounds 10a and 10b were found to be the most potent anti-inflammatory agents in the present study. Meanwhile, 10a and 10b displayed higher selective inhibitory activity towards COX-2 compared to indomethacin. Moreover, compounds 10a and 10b exhibited promising antibacterial against both E. coli and S. aureus. Docking studies for 8b, 10a and 10b with COX-2 (PDB ID: 1CX2) and DNA-gyrase B (PDB ID: 1E11) showed good binding profile. (C) 2010 Elsevier Masson SAS. All rights reserved.
    DOI:
    10.1016/j.ejmech.2010.10.001
点击查看最新优质反应信息